Theory
A passport system for medicines
IDMP (Identification of Medicinal Products) is a suite of ISO standards that together give every medicinal product a globally unambiguous identity — essential for pharmacovigilance, recalls and cross-border drug safety. The ISO documents themselves are paywalled, and regulators (the EMA, FDA) drive their adoption.
- The five core standards — ISO 11615 (medicinal product information), ISO 11616 (pharmaceutical product information), ISO 11238 (substances — the SMS), ISO 11239 (dose forms, units of presentation, routes of administration), and ISO 11240 (units of measurement, leaning on UCUM).
- Why a suite — a 'medicine' is many entangled facts: the marketed product, the abstract pharmaceutical product, the active substances, the strength, the dose form, the units. IDMP gives each facet its own standard and identifier, then ties them together.
- The regulator's registries — the EMA implements IDMP through SPOR: master data for Substances, Products, Organisations and Referentials. These are the authoritative lookups everyone aligns to.
- How it's carried — IDMP concepts are increasingly exchanged via HL7 FHIR medicinal-product resources (and historically SPL), so IDMP is the model and FHIR is often the transport.
Use Case Example: An adverse-event report in Spain references a medicine by its IDMP identifiers — the same product, substance and strength identifiers a regulator in Germany resolves against SPOR. Because both sides speak IDMP, the safety signal aggregates across borders instead of being lost in national naming differences.